Entia Biosciences Inc (ERGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Sales | 94 | 109 | 117 | 84 | 86 |
| Cost of Goods | 32 | 15 | 46 | 39 | 32 |
| Gross Profit | 62 | 93 | 70 | 45 | 54 |
| Operating Expenses | 623 | 234 | 323 | 692 | 278 |
| Operating Income | -533 | -125 | -207 | -608 | -197 |
| Interest Expense | 105 | 76 | 83 | 75 | 72 |
| Other Income | 8 | 0 | 79 | 0 | 0 |
| Pre-tax Income | -630 | -201 | -211 | -683 | -269 |
| Net Income Continuous | -630 | -201 | -211 | -683 | -269 |
| Net Income | $-634 | $-201 | $-211 | $-683 | $-269 |
| EPS Basic Total Ops | -0.11 | -0.03 | -0.03 | -0.11 | -0.21 |
| EPS Basic Continuous Ops | -0.10 | -0.03 | -0.03 | -0.11 | -0.22 |
| EPS Diluted Total Ops | -0.11 | -0.03 | -0.03 | -0.11 | -0.21 |
| EPS Diluted Continuous Ops | -0.10 | -0.03 | -0.03 | -0.11 | -0.22 |
| EBITDA(a) | $-436 | $-53 | $-108 | $-439 | $-126 |